Christopher Andry, MPhil, PhD, was named Chief, Department of Pathology and Laboratory Medicine at Boston Medical Center (BMC) and Chair, Department of Pathology and Laboratory Medicine at Boston University School of Medicine (BUSM) effective September 1, 2019. Dr. Andry’s career at BMC and BU has spanned more than 35 years, during which he has demonstrated a deep-rooted commitment to and passion for the mission of the BMC Health System, BUSM and the Medical Campus, Boston University and the Boston community at large. As Chief and Chair, Dr. Andry will bring his clinical expertise and leadership to the role to ensure a high-quality, integrated, academic department that is innovative, well-resourced, and collaborative.
Dr. Andry served as the Department’s Vice Chair for Operations & Management and Administrative Director for 12 years and is a Professor of Pathology & Laboratory Medicine and Family Medicine, he also is a member of the BU-BMC Cancer Center Executive Committee, and liaison to New England Donor Services.
Dr. Andry is well recognized in the field of biospecimen science. In a team-based setting at BU and BMC, he has established evidence-based protocols and standards to ensure curation and distribution of high-quality, well-annotated biospecimens. Dr. Andry has served as the PI on more than $2 million in NCI funded grants and contracts to set standards for the science of biospecimen collection. Dr. Andry has raised the profile of BU in biobanking and provides the expertise for obtaining usable tissue samples for medical campus research faculty. Dr Andry is focused on supporting research and infrastructure to reduce healthcare disparities for underserved populations and has an interest in cancer biology, specifically prostate and breast cancer.
Dr. Andry received his PhD in pathology from BUSM and his bachelor of science and master of philosophy in biological sciences from the University of Lancaster, United Kingdom. He has published and collaborated on more than 50 articles, reviews and medical texts.
- Associate Professor, Family Medicine, Boston University School of Medicine
- Boston Medical Center
- Member, BU-BMC Cancer Center, Boston University
- Member, Evans Center for Interdisciplinary Biomedical Research, Boston University
- Graduate Faculty (Primary Mentor of Grad Students), Boston University School of Medicine, Graduate Medical Sciences
- Chair, Pathology & Laboratory Medicine, Boston University School of Medicine
- Boston University, PhD
- Lancaster University, MPhil
- Lancaster University, BSc
- Published on 5/6/2021
Kataria Y, Cole M, Duffy E, de la Cena K, Schechter-Perkins EM, Bouton TC, Werler MM, Pierre C, Ragan EJ, Weber SE, Jacobson KR, Andry C. Seroprevalence of SARS-CoV-2 IgG antibodies and risk factors in health care workers at an academic medical center in Boston, Massachusetts. Sci Rep. 2021 05 06; 11(1):9694. PMID: 33958668.
- Published on 9/15/2020
Giadone RM, Mithal A, Miller GJ, Matte TM, Yeung AK, Dowrey TW, Werder RB, Miller NS, Andry CD, Vanuytsel K, Murphy GJ. qRT-PCR Platforms for Diagnosing and Reporting SARS-CoV-2 Infection in Human Samples. STAR Protoc. 2020 Sep 18; 1(2):100102. PMID: 32954369.
- Published on 2/20/2019
Carithers LJ, Agarwal R, Guan P, Odeh H, Sachs MC, Engel KB, Greytak SR, Barcus M, Soria C, Lih CJ, Williams PM, Branton PA, Sobin L, Fombonne B, Bocklage T, Andry C, Duffy ER, Sica G, Dhir R, Jewell S, Roche N, Moore HM. The Biospecimen Preanalytical Variables Program: A Multiassay Comparison of Effects of Delay to Fixation and Fixation Duration on Nucleic Acid Quality. Arch Pathol Lab Med. 2019 09; 143(9):1106-1118. PMID: 30785788.
- Published on 5/8/2017
Andry C, Duffy E, Moskaluk CA, McCall S, Roehrl MHA, Remick D. Biobanking-Budgets and the Role of Pathology Biobanks in Precision Medicine. Acad Pathol. 2017 Jan-Dec; 4:2374289517702924. PMID: 28725790.
- Published on 12/11/2009
Saijo F, Milsom AB, Bryan NS, Bauer SM, Vowinkel T, Ivanovic M, Andry C, Granger DN, Rodriguez J, Feelisch M. On the dynamics of nitrite, nitrate and other biomarkers of nitric oxide production in inflammatory bowel disease. Nitric Oxide. 2010 Feb 15; 22(2):155-67. PMID: 20005300.
- Published on 7/1/2009
Hasturk H, Goguet-Surmenian E, Blackwood A, Andry C, Kantarci A. 1-Tetradecanol complex: therapeutic actions in experimental periodontitis. J Periodontol. 2009 Jul; 80(7):1103-13. PMID: 19563290.
- Published on 11/15/2007
Hasturk H, Kantarci A, Goguet-Surmenian E, Blackwood A, Andry C, Serhan CN, Van Dyke TE. Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. J Immunol. 2007 Nov 15; 179(10):7021-9. PMID: 17982093.
- Published on 5/1/2007
Hasturk H, Jones VL, Andry C, Kantarci A. 1-Tetradecanol complex reduces progression of Porphyromonas gingivalis-induced experimental periodontitis in rabbits. J Periodontol. 2007 May; 78(5):924-32. PMID: 17470028.
- Published on 7/15/2006
Lieberthal W, Fuhro R, Andry C, Patel V, Levine JS. Rapamycin delays but does not prevent recovery from acute renal failure: role of acquired tubular resistance. Transplantation. 2006 Jul 15; 82(1):17-22. PMID: 16861936.
- Published on 4/1/2006
Hasturk H, Kantarci A, Ebrahimi N, Andry C, Holick M, Jones VL, Van Dyke TE. Topical H2 antagonist prevents periodontitis in a rabbit model. Infect Immun. 2006 Apr; 74(4):2402-14. PMID: 16552070.
View 13 more publications: View full profile at BUMC